Novartis India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
1,295.10
-8.75 (-0.67%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 16.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Novartis India With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
354.33
2,260.39
-1,906.06
-84.32%
Other Operating Income
0.00
0.00
0.00
Total Operating income
354.33
2,260.39
-1,906.06
-84.32%
Raw Material Cost
0.00
1,401.85
-1,401.85
-100.00%
Purchase of Finished goods
210.58
45.51
165.07
362.71%
(Increase) / Decrease In Stocks
-12.21
6.62
-18.83
-284.44%
Employee Cost
21.08
96.27
-75.19
-78.10%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
40.78
449.40
-408.62
-90.93%
Total Expenditure (Excl Depreciation)
260.23
1,999.65
-1,739.42
-86.99%
Operating Profit (PBDIT) excl Other Income
94.10
260.74
-166.64
-63.91%
Other Income
38.77
2.59
36.18
1,396.91%
Operating Profit (PBDIT)
132.87
263.33
-130.46
-49.54%
Interest
1.26
26.38
-25.12
-95.22%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
131.61
236.95
-105.34
-44.46%
Depreciation
1.95
55.64
-53.69
-96.50%
Profit Before Tax
129.66
181.31
-51.65
-28.49%
Tax
36.48
12.09
24.39
201.74%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
93.18
169.22
-76.04
-44.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
93.18
169.22
-76.04
-44.94%
Equity Capital
12.34
91.27
-78.93
-86.48%
Face Value
5.00
10.00
0.00
Reserves
805.49
0.00
805.49
Earnings per share (EPS)
37.76
18.54
19.22
103.67%
Diluted Earnings per share
37.74
18.54
19.20
103.56%
Operating Profit Margin (Excl OI)
26.56%
11.54%
0.00
15.02%
Gross Profit Margin
37.14%
10.48%
0.00
26.66%
PAT Margin
26.30%
7.49%
0.00
18.81%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 354.33 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 93.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.10 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

Annual - Interest
Interest 1.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.56%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025